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Aims: To develop MR-based measurement technique to evaluate the postoperative
dimension and location of implanted magnetic resonance (MR)-visible meshes.
Methods: This technique development study reports findings of six patients (A-F)
with cystoceles treated with anterior vaginal MR-visible Fe3O4-polypropylene
implants. Implanted meshes were reconstructed from 3 months and/or 1 year
postsurgical MR-images using 3D Slicer®. Measurements including mesh length,
distance to the ischial spines, pudendal, and obturator neurovascular bundles and
urethra were obtained using software Rhino® and a custom Matlab® program. The
range of implanted mesh length and their placements were reported and compared
with mesh design and implantation recommendations. With the anterior/posterior-
mesh-segment-ratio mesh shrinkage localization was evaluated.
Results: Examinations were possible for patients A-D 3 months and for A, C, E, and F
1 year postsurgical. The mesh was at least 40% shorter in all patients 3 months and/or
1 year postoperatively. A, B showed shrinkage in the anterior segment, D, E in the
posterior segment (Patients C, F not applicable due to intraoperative mesh trimming).
Patient E presented pain in the area of mesh shrinkage. In Patient C posterior mesh
fixations were placed in the iliococcygeal muscle rather than sacrospinous ligaments.
Arm placement less than 20mm from the pudendal neurovascular bundles was seen in
all cases. The portion of the urethra havingmesh underneath it ranged from 19% to 55%.
Conclusions:MRI-based measurement techniques have been developed to quantify
implanted mesh location and dimension. Mesh placement variations possibly
correlating with postoperative complications can be illustrated.
KEYWORDS
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1 | INTRODUCTION
Pelvic organ prolapse (POP) occurs when the viscera move
downward and protrude through the urogenital opening. This
causes distress, abnormal organ function, impaired quality-of-
life—affecting millions of women worldwide.1–3 Vaginal or
transabdominal operations with or without synthetic meshes are
used to restore pelvic floor support.1 Yet, vaginal trocar-guided
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meshes are a controversial topic due to risks of postoperative
complications such asmesh contraction/shrinkage, pudendal, or
obturator neurovascular lesionsdue to armplacement variations,
dyspareunia, or de-novo voiding dysfunction.4–6
Imaging studies providing objective evaluations of these
issues could help us understand how and why complications
arise.1,4,7 Ultrasound as a standard imaging tool in urogyne-
cology8 has demonstrated its ability to visualize the mesh
material and describe its relation to adjacent pelvic organs.9,10
However, it is limitedwhen attempting to visualizemesh deep
in the body, including the anchoring points and their
relationship to neurovascular structures.11 The pudendal
and obturator neurovascular bundles, for example, are at risk
of being injured intraoperatively due to their proximity to the
recommended mesh arm anchoring points.12,13
Newly developed magnetic resonance (MR)-visible
Fe3O4-polypropylene partially absorbable meshes in combi-
nation with pelvic MR-imaging (MRI) allow visual observa-
tion of the full mesh course through the female pelvis, yet
objective measurement schemes are scarce.11 In this study,
we aim to develop measurement techniques to (i) quantify the
dimensions of the implanted mesh to evaluate changes in size
compared to its pre-implant dimension (“shrinkage”); (ii)
measure the distance from implanted mesh to important
pelvic structures and compare them with mesh implantation
recommendations; and (iii) correlate the measurement
information with patients’ clinical results.
2 | MATERIAL AND METHODS
2.1 | Study patients
This is a technique development study based on six patients
from an ongoing prospectivemulti-center clinical trial (Ethical
Board approval number S-473/2007, amendment July 9th,
2015) evaluating women with anterior vaginal mesh repair
using an MR-visible Fe3O4-polypropylene implant. MRI and
clinical examinationswereperformedbefore surgery,3months
post surgery, and 1 year post surgery. All six patients returned
for the 3-month follow-up and two patients (Patients B & D)
opted out for the 1-year visit. The inclusion criteria included
symptomatic ≥POP-Q stage 2 cystocele with apical prolapse,
vaginal mesh surgery with an MR-visible implant, no
contraindication for surgery or MRI, and age ≥18 years.
2.2 | Mesh information and implantation
Two types of partially absorbable (PA) anterior vaginalmeshes
(Seratom® E PA MR or Seratom® P PA MR by Serag
WiessnerGmbH&Co.KG,Naila,Germany)were used.These
two meshes only differ in size and shape (eg, 103mm vertical
mesh length and diamond-shaped body of the SeratomEPAvs
90mm vertical mesh length and rectangular-shaped body in
theSeratomPPA;Supplemental Figure S1).Bothmeshes have
six arms and MR-visible Fe3O4 threads integrated into the
weave, alternating with absorbable fibers expected to be
absorbed approximately 120 days postsurgically.11,12,14,15
Mesh implantations were performed according to the
manufactuerer's recommendations by expert surgeons
(>1000 anterior vaginal meshes implanted). The posterior
arms were to be placed through the sacrospinous ligaments
approximately 2 cm away from the ischial spine, and the
middle and anterior arms were to be placed via the obturator
muscle-membrane-complex using a multi-incision trocar-
guided technique with reusable introducers/needles.11–14
2.3 | Magnetic resonance imaging
All MRIs were acquired in supine position using a 1.5 Tesla
scanner (Siemens Symphony, Siemens Medical Solutions,
Erlangen, Germany).11 High-resolution T2-weighted (T2w)
turbo spin echo sequence on axial, coronal, and sagittal planes
were acquired according to the body axis to visualize the
pelvic anatomy (TR 3460-4219 ms, TE 77-88 ms, matrix
512*282, slice thickness 5-6 mm), whereas T1-weighted
(T1w) FLASH 2D (TR 128-132 ms, TE 4.7 ms, matrix
256*154, slice thickness 6 mm), and FLASH 3D sequences
(TR 15 ms, TE 6 ms, matrix 512*384, slice thickness 1 mm)
were performed to visualize the implanted meshes.11 This
study focused on the analysis of the 3-month and 1-year
postoperative MRIs. The 3-month follow-up MRIs for
patients E and F were excluded from analysis due to poor
image quality caused by MR scanner maintenance issues.
2.4 | Mesh 3D reconstruction and
measurements
In all eligible MRIs at 3 months and 1 year post surgery, the
meshes were visible and 3D mesh models could be
reconstructed, making a direct comparison of the implants
within the same patient possible (Figure 1). All MRIs were
first imported into 3D Slicer® (version 4.5.1) for visualiza-
tion and 3D model reconstruction. Then, two additional post-
processing programs (the modeling software Rhino® and a
custom Matlab® program) were used to perform the
quantitative analysis. We used bony landmark-based method
to align all MRIs instead of automatic rigid/deformable
registration methods to limit the influence of soft tissue
variation of the pelvic organs, such as abdominal wall motion,
movement of intestines, variation of bladder filling, and
intestine contents variation. In 3D Slicer®, we first manually
identify the bony landmarks including the most inferior part
of the pubic symphysis, ischial spines, and the sacrococcygeal
junction on all MRI sequences.11,16 Then a semi-automatic
landmark-based rigid registration method in 3D Slicer® was
used to align all MRI sequences at both the 3-month and
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2-year postoperative exams in the same 3D space with
standardized bony pelvis orientation.11,16 Similarly, MRIs
from the 3-month and 1-year postoperative exams were
aligned. Using the point cloud technique, we reconstructed
the full mesh course by identifying the mesh on T1wMRIs as
hypointense spots compared to surrounding tissue.11 Figure 1
demonstrates the comparison of reconstructed mesh models
obtained fromMRI scans 3 months and 1 year post surgery in
the same patient. Additionally, anatomical structures includ-
ing pudendal and obturator neurovascular bundles, bladder
and urethra with UVJ were reconstructed based on T2w
MRIs.11,17–19 Two observers with extensive experience on
pelvic floor MRI anatomy first independently identified the
point clouds and outlined the structures. Then the point clouds
and models were reviewed, the consensus was reached and
reported as final data.
FIGURE 1 Example of a 3D model reconstruction of the implanted Fe3O4-polypropylene mesh within the same patient (A) at both
examination points. The mesh was marked with yellow dots at the 3-month examination (Panels A, B, C, G) and with green dots at the 1-year
examination (Panels D, E, F, G) on T1-weighted MR-images. The 3D models show the location of the mesh and its fixational arms according to
the bony pelvic frame and the sacrospinous ligament (marked in blue at panels C, F, and G)
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To measure the implanted mesh dimension, mesh point
clouds were imported into the modeling software Rhino®
(R13,RobertMcNeel&Associates, Seattle,WA).Currently, it
is not possible to depict the individual mesh threads; therefore,
a smooth surface fitted on the point clouds was reconstructed
for the mesh body and arms to represent the “effective mesh
surface”—the overall shape and dimension—without consid-
ering the thread pattern and interaction between mesh threads
(Figure 2). To evaluate the potential mesh shrinkage/folding,
the effective length in the middle of the implanted mesh was
measured and compared to the mesh length of the product
before implantation. We noted the anterior segment (the
distance between the anterior and middle arms) and the
posterior segment (the distance between the middle and
posterior arms) to compare to the designed parameters
(Figure 2) allowing us to locate where shortening occurred.
All available postsurgical examinations 3 months and/or
1 year postoperatively were quantified. The dimension and
location of the implanted mesh were measured and compared
to original dimension and implantation recommendation. The
range and number of patients within the recommendations
were reported based on the first available post-operative MR
measurements. Standardized t-test was used to compare the
original and implanted mesh dimension.
FIGURE 2 Example of postoperative mesh changes in two patients. The mesh designed dimension is shown as an insert in the upper middle
of the figure. Mesh shrinkage or possible double layering can be observed in the distal (anterior) mesh part (patient A at 3-month follow-up,
panels A-C) or proximal (posterior) mesh part (patient E at 1-year follow-up, panels D-F). In the postoperative follow-up, the total vertical mesh
length (red line, panels A and D) appeared smaller (patient A: 55 mm; patient E: 60 mm) than the presurgical size (103 mm). Panels B, C, E, and
F demonstrate the cranialcaudal view onto the mesh body (Seratom E PA®, yellow dots/area). The sacrospinous ligaments are marked blue. Ant,
anterior; L, left; Pos, posterior; R, right
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A Matlab® (version 2016) program was developed to
evaluate the postoperative mesh placements by calculating the
minimum distance between the mesh point cloud and important
anatomical structures, such as pudendal and obturator neuro-
vascular bundles (Figure 3). To evaluate whether the posterior
mesh arm implantation achieved the product placement
recommendations, we identified the posterior arm penetration
points as the location where the posterior arm changes direction
(Figure 3, panel C). Next, the distances from the posterior arm
penetration points to the ischial spines were reported.12We also
evaluated whether the posterior arm penetration point was
within the sacrospinous ligament as recommended.12,13 To
evaluate themesh location relative to the ureterovesical junction
(UVJ),wemeasured the length of themesh beneath theUVJ and
reported it as the percentage of the urethrawithmesh underneath
it (Figure 4).
3 | RESULTS
3.1 | Clinical evaluation
We evaluated six women (aged 66-76 years) after anterior
pelvic floor reconstruction with an MR-visible mesh (for
surgery performed and concomitant procedures, see Supple-
mental Table S1). In two cases (Patients C and F,
Supplemental Table S1), the surgeon decided intraoperatively
to trim the anterior mesh part and arms, reducing the mesh
length by approximately 2 cm, because it was too large to fit
the woman's anatomy. No women showed short term intra- or
postoperative complications.
All patients attended the 3-month postoperative follow-
up, which showed no clinical impression of recurrent or de-
novo POP (Supplemental Table S1). Patients A, C, E, and F
returned for the 1-year follow-up. One woman complained
about symptoms (dyspareunia, feeling of a bulge in the
vagina, and defecational problems) deriving from a recurrent
cystocele grade III° and recurrent recto-enterocele grade II°,
detected on follow-up clinical examination. Also, the
posterior arms could be felt as a tight band that caused pain
during Patient E's examination (Supplemental Table S1).
3.2 | MRI measurement results
For first available post-operative MRI evaluation, the median
implanted mesh length was 55 mm (range, 45-58 mm) for
SeratomE PAmesh (patients A, C*Trim, E), and 53 mm (range
38-54 mm) for Seratom P PA mesh (patient B, D, F*Trim).
They are significantly (at least 40%, P< 0.001) shorter than
the original mesh length. Please keep in mind, for Patient
C*Trim and F*Trim, we consider the original mesh length as
trimmed mesh length that is 20 mm shorter than designed
length (Table 1, Supplement Table S1). Variations in middle
arm location in the implanted meshes were observed in
Patient E, demonstrating corresponding clinical findings
(Figure 2, Supplemental Table S1). The anterior and posterior
segments have a similar designed length (Supplemental
Figure S1), resulting in an anterior/posterior segment ratio
close to 1. However, the implanted meshes of patients A and
B show a shorter anterior than posterior segment, resulting in
an anterior/posterior segment ratio much smaller than 1
(Table 1, Figure 2, panels A-C). In contrast, in patient E, the
posterior segment (9 mm) was much shorter than the anterior
segment (49 mm) (Table 1, Figure 2, panels D-F); this
corresponded to the area of pain during palpation in the
clinical exam (Supplemental Table S1).
The distances of the mesh from the obturator, pudendal
neurovascular bundles, and ischial spines are listed in Table 1
and described in Figure 3. The distance of the mesh arms to
obturator neurovascular bundles ranged from 11 to 33 mm. In
five out of six patients these measurements were larger than
FIGURE 3 Close-up image of mesh (region of interest marked as a white block in the orientation insert) in relation to neurovascular structures
and bony pelvis describing possible measurements that can be performed with this technique, for example, the shortest distance between alloplastic
material and anatomic structure of interest. Panel A demonstrates in a craniocaudal view the distance (arrow-headed line, 13mm) measured in 3D
space between the left posterior arm and the left pudendal neurovascular bundle (red dots). Panel B demonstrates the distance (arrow-headed line,
22mm) between the left middle arm and the obturator neurovascular bundle (orange dots). Panel C describes the distance (arrow-headed line,
27mm) from the penetration point of the posterior right arm through the sacrospinous ligament to the right ischial spine (IS_R)
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recommended—providing sufficient safety margins. Simi-
larly, the distance of mesh arms to the ischial spines ranged
from 9 to 34 mm with four out of six patients presenting
measurements larger than the recommendation. However,
posterior mesh arms are significantly closer to pudendal
neurovascular bundles than recommended in all six patients,
with the closest being only 3 mm away (Table 1). In one
patient, the posterior mesh arms were placed not through the
sacrospinous ligaments, but beneath the ligament, through the
iliococcygeal muscle (Patient C, Figure 4, panels A and B,
Supplemental Video). There were no suspicious findings in
either the 3-month or 1-year follow-up clinical examinations
(Supplemental Table S1), but in this patient, the posterior
mesh arm was closest to the pudendal neurovascular bundle
(4 mm away, on average) (Table 1; Supplemental Table S1).
In the midsagittal T1 images of patients A, C, D, E, and F,
the distal part of the mesh extended below (caudal to) the
bladder neck and lay parallel to the urethra. The portion of the
urethra havingmesh underneath it ranged from 19% to 55% of
the total urethra length (Table 1; Figure 4, panels C and D).
No voiding dysfunction was observed.
4 | DISCUSSION
In this study, we developed techniques to measure the
implanted mesh dimensions and location relative to important
pelvic anatomical structures based on 3D reconstruction of
postoperativeMR-images after anterior compartment prolapse
surgery using MR-visible Fe3O4-polypropylene meshes. This
allowed us to compare the dimensions and location of the
actual implanted mesh to the manufacturer's recommenda-
tions. Preliminary findings revealed that implantedmeshes are
>40%shorter than the designedmesh length.Wedemonstrated
that the measurements of the mesh location related to the
ischial spines and neurovascular bundles are feasible in
different subjects and stable within the same patient over time.
We also correlated these measurements with the clinical
findings. The data allowed us to evaluate mesh placement
deviations from manufacturer recommendations12,13 and to
quantify the safetymargin achieved in order to avoid structures
with high risk of injury or complications.
The ability to visualize iron-loaded mesh grafts and their
3D reconstruction has been recently published.11,14,20–22 This
study extends the field by introducing objective measurement
techniques that could be used clinically when evaluatingmesh
implantation techniques, in surgery training programs, and in
situations of recurrent POP or postoperative symptoms. We
are not advocating that all women have preoperative and
postoperative MRIs, but the mesh MR-visibility allows us to
quantify and understand its placement in a research setting or
as a diagnostic tool when complications arise. We recognize
that ultrasound as the imaging tool of choice in most clinical
situations is very effective in visualizing mesh material
between the anterior vaginal wall and the bladder, helping
diagnose mesh folding or dislodgement, and in recurrent
prolapse situations.10,11,23,24 But when trying to evaluate the
mesh arms passing through the deep pelvic structures and
FIGURE 4 With this visualization technique, variations in postoperative mesh location can be revealed as demonstrated here in the 3D
pelvic model of patient C. Panels A and B show the posterior mesh arm's spatial relationship to the sacrospinous ligaments (dark blue). Both
panel A (caudocranial view) and panel B (view from left caudal, outside to inside) reveal the gap between both posterior mesh arms and the
sacrospinous ligaments (Supplemental Video). Panel C shows the 3D model of the mesh (yellow dots) and bladder (light blue) with the middle
sagittal MR-image. The distal part of the mesh runs parallel to the urethra (arrow). Panel D displays this middle sagittal T2 image. The urethral
length (light blue line) and the amount of urethra covered by the distal part of the mesh body (pink arrow) were measured (Panel D). The clinical
follow-up examinations showed no voiding disorders. Red dot points out the left ischial spine; PS, pubic symphysis; R, rectum; SB, small bowel
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body wall, this MR-visible mesh-based technique illuminates
areas of the postoperative pelvic “situs” that were hidden until
now. By simultaneously capturing the entire pelvis and mesh,
this technique can provide additional information in some
complex circumstances, such as postoperative pelvic pain or
recurrent prolapse. In our opinion, the extended time
expenditure and higher costs of this technique can be justified
in these special cases.
Postoperative mesh “shrinkage” is a commonly discussed
topic with controversial opinions in the evaluation of mesh
surgery outcomes.4,7,25 Our results demonstrate that the
overall implanted vertical mesh length was at least 40%
shorter in the 3-month and 1-year postoperative follow-up
examinations compared to the original mesh design—
suggesting possible mesh contraction/folding consistent
with observations from other study teams regarding the
existence of mesh contraction.4,25,26 However, our measure-
ments of mesh size reduction in early postoperative follow-up
examinations are higher than reported by Letouzey et al, with
30%, 65%, and 85% mesh contraction at 3-, 6-, and 8-year
ultrasound follow-up, respectively.4,26 Other reasons for a
shorter measured postoperative mesh length include failed
tension-free mesh insertion with resulting intraoperative
folding4 and a higher local infection status of the surgical
site.27 Another possible explanation formesh folding could be
that the original design's dimension is larger than needed to fit
the anatomical conditions of the patient.
Interestingly, we could also detect notable variations in
terms of where mesh shortening/folding occurred. Our results
demonstrate that this can occur in both the anterior and
posterior parts of themesh.Thismight bedue to the variation of
the initial mesh tension during implantation or to differences in
the anatomical situation in individual patients. It is also worth
mentioning that even though all six cases in this trial had
varying degrees of mesh shortening, only one patient reported
experiencing pelvic pain in the postoperative follow-up. In this
case, mesh reduction occurred in the posterior segment,
matching the pain location reported during clinical examina-
tion. This may be explained by the excessive tension after
shrinkage of the main mesh body against the fixated,
unmovable arms carving into the surrounding scarring soft
tissue. No hematoma or any sign of infection was visible on
MRI in this case to further explain her condition.
The ischial spines are proximate the pudendal nerve and
are commonly used as landmarks for mesh implantation.
Surgery training programs recommend that intraoperatively,
the ischial spine is palpated first. Then, the palpating fingers
are to be moved approximately two centimeters proximal,
sliding along the sacrospinous ligament with the palpating
finger, to find the ideal localization for the penetration of the
posterior mesh arm through the sacrospinous ligament.12,13
Our data showed that the recommended safe penetration
points for the posterior arms relative to the ischial spines were
achieved. But following the further course of the posterior
arms to the point closest to the actual pudendal neurovascular
bundle revealed how close they truly are, with a mean of only
7 mm (left) and 5 mm (right). In our opinion, these results
reinforce the recommendation to place the posterior mesh
arms at least 20 mm proximal to the ischial spine into the
sacrospinous ligament, as the pudendal neurovascular bundle
is closer than anticipated. Our findings provide, for the first
time, quantitative measurements of the distance between
implanted mesh and the pudendal neurovascular bundle in
vivo, which could produce valuable feedback for mesh
designers and manufacturers.
In addition, our technique also identified the deviations
from the recommendations in surgical mesh placement. In
patient C, both posterior mesh arms were placed below the
sacrospinous ligaments into the iliococcygeal muscle,
resulting in considerably closer distances of the posterior
arms to the pudendal neurovascular bundles (3-5 mm) than
recommended. However, it is important to mention that the
clinical results did not reveal complications in this case, so we
cannot conclude that placement deviation necessarily leads to
intra- or postoperative complications—although our de-
scribed technique revealed the smaller safetymargin achieved
with such deviations.
Among other postoperative complications, voiding dys-
functions are frequently mentioned when evaluating vaginal
mesh surgery outcomes. Our results demonstrate that the
implanted mesh extends below the bladder neck, but we could
not detect voiding dysfunction in the postoperative clinical
examination. Our findings are consistent with ultrasound
studies,19,20 but provide more reliable and accurate measure-
ments with better image resolution and a larger field of view.
We acknowledge that the demonstrated technique is
expensive, complex, and difficult to implement into a clinical
routine. In order to perform these measurements, several
conditions are required, such as implantation of an MR-
visible mesh, postsurgical MRI with T1-weighted 2D and 3D
sequences in appropriate slice thicknesses, and image
processing software for 3D reconstruction andmeasurements.
This study was meant to develop the technique and
demonstrate possible objective measurements to extend the
current knowledge. This pilot study group is small and very
heterogeneous with unfortunate missing follow-up and
missing data. Better protocol will be needed to improve the
compliance and retention of the future trail. Larger cohorts
will be needed to evaluate surgery outcomes after implanta-
tion of the Seratom®E PA and Seratom® P PA implants. The
changes in implanted mesh dimension and location over time
and its correlation with clinical implication can then
be investigated systematically in the future. We believe
that the demonstrated technique can be very valuable in
certain clinical settings, such as for diagnosing complex mesh
complications, and for research in this field.
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Our results demonstrate that this MRI-based measurement
technique can precisely and objectively evaluate postopera-
tive location and dimension of Fe3O4-polypropylene meshes,
illustrate mesh placement variations, and identify possible
complications.
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